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Key points 
 Magnetic resonance spectroscopy (MRS) offers invaluable information about living 
tissues with special contribution to the diagnosis and prognosis of the central 
nervous system diseases. 
 Diffusion tensor imaging (DTI) detects subtle degradation of white matter 
microstructure in fibromyalgia.  
 Perfusion magnetic resonance imaging (MRI) offers higher spatial resolution than 
radionuclide techniques such as positron emission tomography and single-photon 
emission computed tomography. 
 Voxel-based morphometry (VBM) is a recent methodology that can simultaneously 
visualize group differences or statistical effects on gray and white matter, 
throughout the whole brain. 
 Functional magnetic resonance imaging (fMRI) studies regularly confirm that 
multiple brain regions are invoked to execute even ostensibly simple tasks. 
 
1. Introduction 
Imaging human internal organs with exact and non-invasive methods is very important in 
medicine for medical diagnosis, treatment and follow-up, as well as for clinical research. 
Today, one of the most important tools for this purpose is magnetic resonance imaging 
(MRI). MRI scanners are based on the nuclear magnetic resonance (NMR) phenomenon, 
which was detected independently by Bloch, Purcell et al. in 1946. The advent of 
neuroimaging techniques yielding neuropsychological data in addition to structural 
information was of particular interest for scientific and clinical research into fibromyalgia 
and psychiatric disorders. These are groups of conditions for which any structural changes 
evident in anatomical imaging sequences generally correlate poorly with clinical diagnostic 
categories, pointing to underlying pathophysiology and severity of disease. T1- and T2-
dependent MR sequences, the mainstay of routine clinical neuroimaging, are frequently 
insensitive to the underlying pathological processes in these conditions. Focal or global 
atrophy due to associated neuronal loss is also frequently absent. 
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The remit of this section is an overview of some general issues concerning the application of 
spectroscopy, diffusion, perfusion, morphometry and functional techniques in fibromyalgia, 
and their clinical impact in the context of other available tests. 
 
2. Magnetic Resonance Spectroscopy (MRS)  
This technique enables us to study the chemical composition of living tissues. It is based on 
the chemical shift of atoms. The concentration of some metabolites is determined from 
spectra that may be acquired in several ways. 
 
3. Voxel placement 
Currently the spectra may be acquired with single-voxel (SV) or multivoxel techniques 
(MV). The SV technique is readily available on most scanners. Voxels must be positioned 
away from sources of susceptibility artifacts and lipids. For diffuse processes, a 2 x 2 x 2-cm 
(8 cm3) voxel is routinely used. For local lesions, the SV can be reduced in volume. The SV 
technique offers the advantages of better spatial location, more homogeneity, better water 
suppression and speed. However, only one spectrum can be obtained per acquisition. 
However, The MV technique makes it possible to obtain multiple spectra simultaneously 
per acquisition and to assess a greater area of the brain but with smaller spectral resolution. 
To date, the SV is still superior to MV on the grounds of reproducibility (Sauter et al., 1991; 
Hsu et al., 1999, 2001; Law et al., 2004). For both SV and MV, the MR scanner employs a 
process known as shimming to narrow peak linewidths within the spectra. For SV studies, 
improving field homogeneity is performed with basic, zero-ordered shimming on clinical 
MR scanners. For MV, the simultaneous production of uniform field homogeneity in 
multiple regions requires higher order shimming. To obtain high-quality spectra, blood 
products, air, fat, necrotic areas, cerebrospinal fluid, metal, calcification and bone should be 
avoided. In such areas differing magnetic susceptibility results in a non-homogenous field 
that hinders the production of diagnostic quality spectra. 
 
4. MRS pulse sequence 
Two different approaches are generally used for proton spectroscopy of the brain: a) single-
voxel methods based on the stimulated echo acquisition mode (STEAM) and b) point 
resolved spectroscopy (PRESS) pulse sequences and spectroscopy imaging (SI), also known 
as chemical shift imaging (CSI). These latter studies are usually done in two dimensions, 
using a variety of different pulse sequences (spin-echo (SE), usually PRESS).  
The basic principle underlying single-voxel localization techniques is to use three mutually 
orthogonal slice selective pulses and design the pulse sequence to collect only the echo 
signal from the point (voxel) in space where all three slices intersect. In STEAM, three 90º 
pulses are used and the stimulated echo is collected. All other signals (echoes) should be 
dephased by the large crusher gradient applied during the so-called mixing time. Crusher 
gradients are necessary for consistent formation of the stimulated echo and removal of 
unwanted coherences. In PRESS, the second and third pulses are refocusing (180º) pulses, 
and crusher gradients are applied around these pulses to select the desired SE signal arising 
from all three RF pulses and dephasing unwanted coherences. STEAM and PRESS are 
generally similar but differ in a few key aspects. 
With regard to the mode of acquisition, PRESS can be performed with short and long echo 
times (TEs) and there is complete recovery of signal. STEAM can be performed with very 
short TEs, but there is incomplete recovery of signal and a precise volume element (voxel) is 
formed. The PRESS mode is used more than STEAM because it increases the signal/noise 
ratio and is less sensitive to movement artifacts (Maheshwari et al. 2000). A short TE (20-40 
ms) allows us to increase the signal/noise ratio and to visualize most metabolite peaks, with 
the inconvenience of some degree of peak overlapping of. Time matters in clinical practice, 
so short TEs are preferable. In our experience with a 1.5T GE Signa Horizon-clinical scanner 
a TE of 30 ms and a TR of 2500 ms have proven valuable (Fayed et al., 2006). Recently, a TE-
averaged PRESS technique has been yielding highly simplified spectra with better 
suppression of signals not pertaining to assessed metabolites, such as that of 
macromolecules. TE is increased from 35 ms to 355 ms in steps of 2.5 ms with two 
acquisitions per step (Hancu et al., 2005). 
 
5. MR spectra quantification 
The most commonly used spectroscopy is that originating from a Hydrogen nucleus (proton 
1H-MRS). This technique is based on the differences in resonance obtained from hydrogen 
nuclei depending on the surrounding atoms (chemical shift). Each metabolite being assessed 
discloses a different hydrogen resonance frequency and appears in a different site in the 
spectrum. The most frequently evaluated metabolites are N-acetyl-aspartate (NAA), myo-
inositol (mI), choline (Ch), creatine (Cr) and glutamate+glutamine (Glx). The position of the 
metabolite signal is identified on the horizontal axis by its chemical shift, scaled in units 
referred to as parts per million (ppm). With the appropriate factors considered, such as the 
number of protons, relaxation times and so forth, a signal can be converted into a metabolite 
concentration by measuring the area under the curve. Because water is the main component 
of living beings and its concentration is much higher than that of metabolites, it becomes 
necessary to suppress the resonance signal from the hydrogen of water (Maheshwari et al. 
2000 and Bonavita et al. 1999). A plot showing peak amplitudes and frequencies is obtained. 
Each spectrum shows peaks corresponding to the different metabolite values: Myo-inositol 
(mI), 3.56 and 4.06 ppm; Choline compounds (Ch), 3.23 ppm; Creatine (Cr), 3.03 and 3.94 
ppm; y N-acetil-aspartate (NAA), 2.02; 2.5 and 2.6 ppm; glutamine and glutamate (Glx), 2.1-
2.55 ppm and 3.8 ppm . Ratios between metabolites and creatine are also of great value as 
they counteract the systematic errors of measurements. 
 
6. Fitting of model spectra 
A more recent program, called a linear combination model (“LCModel”) (Provencher, 1993), 
fits in vivo spectra as a linear superposition of high-resolution “basis” spectra that are 
acquired from model solutions of the metabolites present in the organ of interest. 
Advantages of LCModel are that all pre-processing steps, automatic phase correction as well 
as modelling of a smooth baseline are included. Standardized basis sets are available for the 
most common clinical MR machines (both 1.5 and 3 T). 
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concentration by measuring the area under the curve. Because water is the main component 
of living beings and its concentration is much higher than that of metabolites, it becomes 
necessary to suppress the resonance signal from the hydrogen of water (Maheshwari et al. 
2000 and Bonavita et al. 1999). A plot showing peak amplitudes and frequencies is obtained. 
Each spectrum shows peaks corresponding to the different metabolite values: Myo-inositol 
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2.55 ppm and 3.8 ppm . Ratios between metabolites and creatine are also of great value as 
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most common clinical MR machines (both 1.5 and 3 T). 
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7. Fibromyalgia 
Fibromyalgia is a chronic and disabling musculoskeletal pain disorder of unknown, 
characterized by a history of widespread pain for at least three months and patients 
reporting of tenderness in at least 11 of 18 defined tender points when digitally palpated 
with about 4 kg per unit area of force. Other frequent accompanying symptoms are fatigue, 
sleep disturbance and depressed mood (Wolfe et al, 1990; Giesecke et al, 2003). With an 
estimated lifetime prevalence of 2% in community samples (Wolfe et al, 1995), it accounts 
for 15% of outpatient rheumatology visits and 5% of primary care visits (Wolfe 1989). The 
prognosis for symptomatic recovery is generally poor (Wolfe et al., 1997). Recent meta-
analysis (Garcia Campayo et al., 2008) demonstrates that both pharmacological and 
psychological treatments show moderate effectiveness with a mean effect size of 0.49. The 
variables that related most with improvement in outcome were younger age of the patients 
and shorter duration of the disorder. On the contrary, gender and type of treatment 
(pharmacological or psychological) did not affect outcome (Garcia Campayo et al., 2008).   
 
8. Usefulness of different neuroimaging techniques in Fibromyalgia 
a) 1H MRS in Fibromyalgia patients 
Glutamate has been implicated as an important mediator in the neurotransmission, 
potentiation, and negative affect associated with pain, and it has been related to chronic 
pain sensitization (Dickenson et al., 2002). Experimental pain models for fibromyalgia have 
revealed elevated glutamate levels in the posterior insula. MRS spectroscopy studies have 
shown that dynamic changes in glutamate and glutamine levels in the insula were 
associated with improvements in clinical and experimental pain in fibromyalgia (Harris et 
al., 2008). Also, a recent MR spectroscopy study concludes with the involvement of the 
posterior insula in pain (Harris et al., 2009) 
A previous MRS study by our group demonstrated the differences in metabolites between 
FM patients and controls. (A) 
Our data suggest that Glx plays a role in this augmented pain processing in those 
individuals who have elevated Glx levels, which is entirely consistent with the literature and 
knowledge regarding FM. In our study there is a significant correlation in the posterior 
cingulate gyrus between Glu+Gln (Glx) and Glx/Cr with depression, pain measured in an 
objective way, such as by sphygmomanometer, and global function assessed with the 
Fybromyalgia Impact Questionnaire (FIQ). Since astrocytes participate in the uptake, 
metabolism, and recycling of glutamate, we hypothesize that an astrocyte deficit may 
account for the alterations in glutamate/GABA neurotransmission in depression. Factors 
such as stress, excess glucocorticoids, altered gene expression of neurotrophic factors and 
glial transporters, and changes in extracellular levels of neurotransmitters released by 
neurons may modify glial cell numbers and affect the neurophysiology of depression 
(Rajkowska et al., 2007). Other studies found that absolute concentrations of Glx, Glu, and 
creatine+phosphocreatine (Cr) were significantly higher in adult bipolar patients in all 
mood states compared to healthy controls (Yildiz-Yesiloglu et al. 2006).  
Elevated Glx inside the astrocyte leads to increased cellular osmolarity in the brain. Within 
30 minutes of glutamate administration, electron microscopy reveals massive acute swelling 
of neuronal cell bodies and dendrites. Consequently, water shifts from the extracellular fluid 
space to the intracellular fluid space resulting in edema of the astrocytes. Relevant clinical 
manifestations are thought to be secondary to this edema (Häussinger et al., 2000). To 
compensate for the increased cellular osmolarity, myo-inositol shifts to the extracellular 
fluids space, leading to a reduction in its concentration inside the astrocyte. In consequence, 
Glx is an excitatory amino acid, and its increase indicates that the metabolic function of 
patients with fibromyalgia differs from controls. Elevation of Gln levels may result in 
permanent cerebral damage. 
In addition, high correlations were found between some clinical variables and certain brain 
metabolites, for instance: ratios of myo-Inositol/Creatine and NAA + N-acetyl aspartyl 
glutamate (NAA+NAAG) in the left hippocampus with pain; myo-Inositol in the right 
hippocampus and myo-Inositol in the posterior cingulate gyrus with catastrophization. 
A recent HMRS study, showed decreased NAA levels within the hippocampus of 
individuals with FM (Wood et al., 2009). In another study, a reduction in the absolute 
concentration of NAA in the right and left hippocampi was reported in a sample of 15 
patients with fibromyalgia (Emad et al. 2008). Lower hippocampal NAA levels suggest 
neuronal or axonal metabolic dysfunction, or some combination of these processes. 
Neuronal loss in the hippocampus has not yet been studied in our series. This should be 
assessed in further studies, in order to gauge atrophic changes within the hippocampus. 
Some studies found that the persistence of elevated Ca2+ in hippocampal neurons exposed 
to glutamate correlated with the extent of neuronal death, and that a large rise in Ca2+ in 
cultured hippocampal neurons, following glutamate application, predicted cell death 
(Mattson et al., 1989). Hippocampal dysfunction may be partly responsible for some of the 
phenomena associated with FM. Blocking NMDA receptors in the hippocampal formation 
reduces nociceptive behaviours; this in turn supports the hypothesis that the hippocampal 
formation is involved in pain-related neural processing and expression of pain-related 
behaviours (McKenna et al. 2001). 
Finally, our study confirms the reduction in myo-Inositol levels in both hippocampi and 
reduction in myo-Inositol/Cr ratios in the left hippocampus and sensitivomotrice area. In all 
cases, brain metabolites were lower in the patient group compared to controls. Changes in 
myo-Inositol have previously been described in patients suffering from bipolar disorder 
(Silverstone et al. 2005). Research suggests that lithium functions primarily by decreasing 
myo-inositol concentrations in bipolar patients (Harwood et al., 2005). 
Patients suffering from clinical depression generally have decreased levels of inositol in 
their cerebrospinal fluid (Barkai et al., 1978). This deficiency could be explained by a 
reduced synthesis or more interestingly by an increased consumption of the compound 
(Lentner, 1986). We speculate that myo-Inositol might, via its conversion to glucuronic acid, 
be consumed in protective detoxification reactions of the brain and could be associated with 
depression. 
 
b) Diffusion Tensor Imaging (DTI)  
White matter structure 
Neuroimaging reveals changes in the white matter (WM) structure in the human brain. 
White matter comprises half of the human brain and consists of bundles of myelinated 
axons connecting neurons in different brain regions (Fields, 2008). Grey matter is composed 
of neuronal cell bodies and dendrites concentrated in the outer layers of the cortex. 
Microstructural changes in white matter can be revealed by specialized MRI brain imaging 
techniques such as diffusion tensor imaging (DTI). This method analyses the of proton 
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axons connecting neurons in different brain regions (Fields, 2008). Grey matter is composed 
of neuronal cell bodies and dendrites concentrated in the outer layers of the cortex. 
Microstructural changes in white matter can be revealed by specialized MRI brain imaging 
techniques such as diffusion tensor imaging (DTI). This method analyses the of proton 
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diffusion in tissue, which is more restricted in white matter than in grey matter. The 
anisotropy increases with increased myelination, diameter and axon compaction.  
 
DTI measurement 
Water molecules in the brain are in constant Brownian motion, and although the movement 
of theses protons affects conventional structural imaging, diffusion weighted imaging (DWI) 
and diffusion tensor imaging (DTI) allow quantification of this microscopic movement 
within each voxel. The main advantage of using DTI, rather than DWI, is that DTI reflects 
the underlying diffusion properties of the sample, independently of the orientation of the 
tissue with respect to the direction of measurements. DTI is thus a robust quantitative 
technique that is independent of how the subject has been oriented inside the scanner 
magnet and gradient coils. In regions with few or no constraints imposed by physical 
boundaries, such as CSF in the ventricles, water movement is random in every direction and 
is isotropic. In contrast to CSF, the path of a water molecule in a WM fibre is constrained by 
physical boundaries, such as the axon sheath, causing the movement along the long axis of a 
fibre to be greater than radial diffusion across the.  
These data can be used to calculate the probable anatomy of white matter bundles in living 
brain, a process called tractography. Orientation is calculated from the eigenvectors defining 
proton diffusion in three dimensions in each voxel. Using algorithms, the principal 
eigenvalue vector is connected to the next voxel to trace the fibre structure and orientation 
in white matter tracts (Jones et al., 2002) 
Diffusion tensor imaging (DTI) yields quantitative measures for tissue water mobility as a 
function of the direction of water motion and is probed by application of diffusion-
sensitization gradients in multiple directions (Basser et al., 1996). Basser et al. describe the 
use of multivariate linear regression to calculate D from a non-diffusion-weighted image 
plus six or more diffusion-weighted measurements in a non-collinear direction. The 
diffusion weighting is obtained by simultaneously applying diffusion gradients along 
combinations of the three physical axes.  
The appropriate mathematical combination of the directional diffusion-weighted images 
provides quantitative measures of water diffusion for each voxel via the apparent diffusion 
coefficient (ADC), as well as the degree of diffusion directionality, or anisotropy (Sundgren 
et al. 2004). Myelin is a major diffusion barrier for water, and gives white matter its high 
anisotropy. Demyelinating diseases are characterized by partial or total loss of myelin, with 
consequent loss of neuronal function. 
 
Fibromyalgia 
DTI allows in vivo mapping of the anatomic connections in the human brain; previous 
studies have identified and confirmed the existence of an anatomic circuitry for the 
functionally characterized top-down influences on pain processing via brainstem structures 
in humans (Hadjipavlou et al., 2006) Fractional anisotropy (FA) is a measure of the portion 
of the diffusion tensor from anisotropy. 
Previous studies with diffusion tensor imaging in FM patients showed alterations in the 
right thalamus and significantly lower fractionated anisotropy in comparison with controls. 
A negative correlation was seen between the FA values in the right thalamus and clinical 
pain in the FM group (Sundgren et al., 2007). Other authors confirmed that DTI in the brain 
of patients with FM appears to be more sensitive than volumetric imaging of voxel-based 
morphometry (VBM) and increased pain intensity scores were correlated with changes in 
DTI measurements in the right superior frontal gyrus. Increased fatigue was correlated with 
changes in the left superior frontal and left anterior cingulate gyrus, and self-perceived 
physical impairment was correlated with changes in the left postcentral gyrus. Higher 
intensity scores for stress symptoms were correlated negatively with diffusivity in the 
thalamus and FA in the left insular cortex (Lutz et al., 2008). 
In a previous study by our group, DWI and DTI were not sensitive enough to detect changes 
in fibromyalgia patients. This may be explained because intraparenchymal injection of 
glutamate or other excitatory aminoacids cause neuronal cell bodies and dendrites to be 
predominantly affected, whereas axons and terminal boutons, originating from cell bodies 
outside of the affected region, remain largely intact (Coyle et al., 1981). 
 
c) Perfusion MRI  
Positron emission tomography (PET) (Jones et al., 1991) and single-photon emission 
computed tomography (SPECT) (Kwiatek et al., 2000) have been used to identify focal 
changes in regional cerebral blood flow (CBF) in patients with fibromyalgia. However, the 
low spatial resolution of PET and SPECT, and the ionizing radiation emitted from the 
nuclear medicine tracers are major concerns. MR perfusion techniques have also been 
developed and offer higher spatial resolution without the use of ionizing radiation (Rosen et 
al., 1990; Belliveau et al., 1990; Detre et al., 1992). 
MR perfusion techniques are based on exogenous or endogenous tracers. In the method 
based on exogenous tracers, a paramagnetic agent such as gadolinium dimeglumine 
gadopentate (Gd-DTPA) is injected, and the resulting decrease and subsequent recovery of 
the MR signal is used to estimate perfusion (Ostergaard et al., 1996; Liu et al., 1999). In the 
method using endogenous tracers, the magnetization of the spins of arterial water are non-
invasively labelled using radiofrequency (RF) pulses, and the regional accumulation of the 
label is measured in the tissues by comparison with an image acquired without labelling 
(Edelman et al., 1994; Kim, 1995; Kwong et al., 1995). 
 
d) Voxel-based morphometry (VBM) 
Tissue volumes in the CNS, and in particular changes in volume over time, are sensitive 
markers of a range of neurological disease states and disease progression. Measurement of 
brain volume requires segmentation of the brain from the rest of the tissues in the head and 
neck. Whilst this can be performed manually or in a semiautomated fashion (see for 
example Harris et al., 1999; Bokde et al., 2002), automated procedures are likely to be more 
reproducible and rapid. This is understandable as the size of the structures involved is 
usually relatively small, making the analysis less tedious than a manual segmentation of the 
whole brain. Additionally, many structures, such as the hippocampus, are difficult to 
segment in an automated fashion, but are relatively easily identified and manually or 
semiautomatically outlined, given appropriate software. Some progress has been made in 
automating segmentation procedures, with methods including the use of deformable shape 
models.  
Tensor-based morphometry (TBM) is a relatively new image analysis technique that 
identifies regional structural differences in the brain, across groups or over time, from the 
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diffusion in tissue, which is more restricted in white matter than in grey matter. The 
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Fibromyalgia 
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nuclear medicine tracers are major concerns. MR perfusion techniques have also been 
developed and offer higher spatial resolution without the use of ionizing radiation (Rosen et 
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MR perfusion techniques are based on exogenous or endogenous tracers. In the method 
based on exogenous tracers, a paramagnetic agent such as gadolinium dimeglumine 
gadopentate (Gd-DTPA) is injected, and the resulting decrease and subsequent recovery of 
the MR signal is used to estimate perfusion (Ostergaard et al., 1996; Liu et al., 1999). In the 
method using endogenous tracers, the magnetization of the spins of arterial water are non-
invasively labelled using radiofrequency (RF) pulses, and the regional accumulation of the 
label is measured in the tissues by comparison with an image acquired without labelling 
(Edelman et al., 1994; Kim, 1995; Kwong et al., 1995). 
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Tissue volumes in the CNS, and in particular changes in volume over time, are sensitive 
markers of a range of neurological disease states and disease progression. Measurement of 
brain volume requires segmentation of the brain from the rest of the tissues in the head and 
neck. Whilst this can be performed manually or in a semiautomated fashion (see for 
example Harris et al., 1999; Bokde et al., 2002), automated procedures are likely to be more 
reproducible and rapid. This is understandable as the size of the structures involved is 
usually relatively small, making the analysis less tedious than a manual segmentation of the 
whole brain. Additionally, many structures, such as the hippocampus, are difficult to 
segment in an automated fashion, but are relatively easily identified and manually or 
semiautomatically outlined, given appropriate software. Some progress has been made in 
automating segmentation procedures, with methods including the use of deformable shape 
models.  
Tensor-based morphometry (TBM) is a relatively new image analysis technique that 
identifies regional structural differences in the brain, across groups or over time, from the 
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gradients of the deformation fields that warp images to a common anatomical template. The 
anatomical information is encoded in the spatial transformation. Therefore, accurate inter-
subject non-rigid registration is an essential tool. With the new advent of recent and 
powerful non-rigid registration algorithms based on the large deformation paradigm, TBM 
is being increasingly used (Lepore et al., 2008; Chiang et al., 2007; Lee et al., 2007). 
In FM, Valet et al. (2009) found significant grey-matter decreases in the prefrontal, cingulate, 
and insular cortex. These regions are known to be critically involved in the modulation of 
subjective pain experiences. Patients presented a decrease in grey matter volume in the 
prefrontal cortex, the amygdala, and the anterior cingulate cortex (ACC). The duration of 
pain or functional pain disability did not correlate with grey matter volumes. A trend of 
inverse correlation of grey matter volume reduction in the ACC with the duration of pain 
medication intake has been detected. Some authors (Burgmer et al., 2009) suggest that 
structural changes in the pain system are associated with FM. As disease factors do not 
correlate with reduced grey matter volume in areas of the cingulo-frontal cortex and the 
amygdala in patients, one possible interpretation is that volume reductions might be a 
precondition for central sensitization in fibromyalgia. 
 
e) Functional MR imaging (fMRI) 
Another more recent imaging method is functional MRI (fMRI) for the mapping of 
activation patterns in the brain. This is an important technique for better understanding of 
brain function. When a brain region is activated, new energy must be transported to this 
region, which leads to increased blood flow to that part of the brain. This can be imaged by 
repetitive MR scans and detected by appropriate signal processing methods.  
Over the years, many have viewed Fibromyalgia syndrome (FMS) as a so-called "functional 
disorder" and patients have experienced a concomitant lack of interest and legitimacy from 
the medical profession. The symptoms have not been explained by peripheral mechanisms 
alone or by specific central nervous system mechanisms. 
Functional MRI blood oxygenation level dependent activation studies on patients who have 
FM have demonstrated augmented sensitivity to painful pressure and the association of this 
augmentation with variables such as depression and catastrophizing, and have also been 
used to evaluate the symptoms of cognitive dysfunction. 
The fMRI-analysis by Jensen et al. (2009), revealed no differences in activity in brain regions 
related with attention and affection or regions with sensory projections from the stimulated 
body area. However, when there is a primary lesion in the descending pain regulating 
system (the rostral anterior cingulate cortex), the patients failed to respond to pain 
provocation. The attenuated response to pain in these cases is the first demonstration of a 
specific brain region where the impairment of pain inhibition in FMS patients is expressed. 
These results validate previous reports of dysfunctional endogenous pain inhibition in FM, 
and advance the understanding of the central pathophysiologic mechanisms, providing a 
new direction for the development of successful treatments in FM. 
Fibromyalgia is the prototypical functional chronic pain condition, and it affects 2-4% of 
individuals. Although the aetiology of this disorder remains largely unknown, emerging 
data suggest that FM arises through augmentation of central pain processing pathways. This 
hypothesis is largely based upon findings of previous functional neuroimaging studies 
showing that FM patients display augmented neuronal responses to both innocuous and 
painful stimuli (Gracely et al., 2002; Cook et al., 2004), confirming the allodynia and 
hyperalgesia seen in this condition (Petzke et al., 2003). 
Studies with functional neuroimaging support the hypothesis of central pain augmentation 
in FMS. Differences of activation in the fronto-cingulate cortex, the supplemental motor 
areas and the thalamus were found between both groups with distinct differences in BOLD-
signals changes over the time course of pain stimulation, even during anticipation of pain. 
These results support the hypothesis that central mechanisms of pain processing in the 
medial pain system, favourable cognitive/affective factors even during the anticipation of 
pain, may play an important role for pain processing in patients with FMS (Burgmer et al., 
2009). 
 
9. Summary, conclusions and future directions 
In this chapter, several techniques used for the diagnosis of fibromyalgia are discussed. At 
present, there are no other non-invasive techniques that can provide equivalent information 
and, as a consequence, MRS, DTI tractography and functional MRI are expected to be a 
powerful combined technique for researching brain anatomy and disease in situ in human 
beings. 
Diffusion tensor imaging (DTI) in combination with magnetic resonance spectroscopy 
(MRS) and functional MRI (fMRI) may provide clinicians with information about ongoing 
pathological changes in FM. Future studies may investigate whether DTI can detect Many 
factors may influence the ability of DTI to discriminate patients with FM from healthy 
individuals. These factors include the field strength of the magnet, spatial resolution, signal-
to-noise ratio, contrast-to-noise ratio and image artifacts. DTI and MRS are non-invasive and 
do not require the use of radioactive tracers, suggesting its potential safe application for 
longitudinal follow-up and repeated assessments. 
Continued improvements in the design of imaging equipment and analysis algorithms are 
progressively improving the specificity of the biological parameters that can be calculated, 
allowing detailed quantitative characterization of microvascular structure in a wide range of 
pathological tissues, including fibromyalgia. 
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 Fig. 2. Diffusion Tensor Imaging 
Example of color-encoded fiber orientation maps. Fibers that are predominantly oriented left–right are 
shown in red, anterior–posterior fibers are shown in green, and superior–inferior fibers are shown in 
blue. 
 
 Fig. 3. Perfusion study 
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